Scaled Biolabs
San Francisco
About Scaled Biolabs
Scaled Biolabs is pioneering a Cell Therapy Discovery Engine, working at the frontier of microfluidics, automation, and machine learning to develop best-in-class cell-based medicines. This engine enables leading biotech and pharma companies to survey hundreds of parameters across tens of thousands of experimental processes, providing an unprecedented window into cell-driven biology. This enables the development of novel and optimal cell-based products and processes, simplifying manufacturing, reducing time to market, and improving clinical outcomes. Scaled Biolabs also develops cell therapy assets internally, including a CIRM-funded program focusing on iPSC-derived dopaminergic neurons as a curative cell therapy for Parkinson’s disease.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $907.5K
- Funding stage: Seed
- Last round: Seed (Oct 2017)
- Website: scaledbiolabs.com
- Phone: +114156551868
Industries & Categories
Biotechnology
Social Profiles
Canonical: https://fsome.com/organization/scaled-biolabs-125979 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.